SwePub
Sök i LIBRIS databas

  Extended search

L773:1936 5233
 

Search: L773:1936 5233 > (2015-2019) > Affinity Proteomics...

  • Byström, SannaKTH,Proteomik och nanobioteknologi,Science for Life Laboratory, SciLifeLab,KTH Royal Inst Technol, Affin Prote, SciLifeLab, S-17165 Solna, Sweden. (author)

Affinity Proteomics Exploration of Melanoma Identifies Proteins in Serum with Associations to T-Stage and Recurrence

  • Article/chapterEnglish2017

Publisher, publication year, extent ...

  • Neoplasia Press, Inc.2017
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:kth-209601
  • https://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-209601URI
  • https://doi.org/10.1016/j.tranon.2017.03.002DOI
  • https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-139020URI
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-333614URI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • QC 20170621
  • BACKGROUND: Blood-based proteomic profiling may aid and expand our understanding of diseases and their different phenotypes. The aim of the presented study was to profile serum samples from patients with malignant melanoma using affinity proteomic assays to describe proteins in the blood stream that are associated to stage or recurrence of melanoma. MATERIAL AND METHODS: Multiplexed protein analysis was conducted using antibody suspension bead arrays. A total of 232 antibodies against 132 proteins were selected from (i) a screening with 4595 antibodies and 32 serum samples from melanoma patients and controls, (ii) antibodies used for immunohistochemistry, (iii) protein targets previously related with melanoma. The analysis was performed with 149 serum samples from patients with malignant melanoma. Antibody selectivity was then assessed by Western blot, immunocapture mass spectrometry, and epitope mapping. Lastly, indicative antibodies were applied for IHC analysis of melanoma tissues. RESULTS: Serum levels of regucalcin (RGN) and syntaxin 7 (STX7) were found to be lower in patients with both recurring tumors and a high Breslow's thickness (T-stage 3/4) compared to low thickness (T-stage 1/2) without disease recurrence. Serum levels of methylenetetrahydrofolate dehydrogenase 1-like (MTHFD1L) were instead elevated in sera of T3/4 patients with recurrence. The analysis of tissue sections with S100A6 and MTHFD1L showed positive staining in a majority of patients with melanoma, and S100A6 was significantly associated to T-stage. CONCLUSIONS: Our findings provide a starting point to further study RGN, STX7, MTHFD1L and S100A6 in serum to elucidate their involvement in melanoma progression and to assess a possible contribution to support clinical indications.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Fredolini, ClaudiaKTH,Proteomik och nanobioteknologi,Science for Life Laboratory, SciLifeLab,KTH Royal Inst Technol, Affin Prote, SciLifeLab, S-17165 Solna, Sweden.(Swepub:kth)u11xul3s (author)
  • Edqvist, Per-Henrik DUppsala universitet,Experimentell och klinisk onkologi,Science for Life Laboratory, SciLifeLab,Forskargrupp Tobias Sjöblom(Swepub:uu)peedq227 (author)
  • Nyaiesh, Etienne-NicholasKTH,Proteomik och nanobioteknologi,Science for Life Laboratory, SciLifeLab,KTH Royal Inst Technol, Affin Prote, SciLifeLab, S-17165 Solna, Sweden.(Swepub:kth)u17qmvab (author)
  • Drobin, KimiKTH,Proteomik och nanobioteknologi,Science for Life Laboratory, SciLifeLab,KTH Royal Inst Technol, Affin Prote, SciLifeLab, S-17165 Solna, Sweden.(Swepub:kth)u130lrx0 (author)
  • Uhlén, MatthiasKTH,Proteomik och nanobioteknologi,Science for Life Laboratory, SciLifeLab,KTH Royal Inst Technol, Affin Prote, SciLifeLab, S-17165 Solna, Sweden.(Swepub:kth)u1dulvmw (author)
  • Bergqvist, MichaelUppsala universitet,Umeå universitet,Institutionen för strålningsvetenskaper,Centre for Research and Development, Uppsala University, 751 85 Uppsala, Sweden; Region Gävleborg, Gävle sjukhus, 801 88 Gävle, Sweden,Centrum för klinisk forskning, Gävleborg,Gavle Sjukhus, S-80188 Gavle, Sweden.;Umea Univ, Dept Radiat Sci, S-90187 Umea, Sweden.(Swepub:uu)michberg (author)
  • Ponten, FredrikUppsala universitet,Science for Life Laboratory, SciLifeLab,Klinisk och experimentell patologi(Swepub:uu)fredpont (author)
  • Schwenk, Jochen M.KTH,Proteomik och nanobioteknologi,Science for Life Laboratory, SciLifeLab,KTH Royal Inst Technol, Affin Prote, SciLifeLab, S-17165 Solna, Sweden.(Swepub:kth)u1h7wtme (author)
  • KTHProteomik och nanobioteknologi (creator_code:org_t)

Related titles

  • In:Translational Oncology: Neoplasia Press, Inc.10:3, s. 385-3951944-71241936-5233

Internet link

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view